Citius Pharmaceuticals earnings were -$40.7M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest CTXR earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$9.8M, down 15.2% from last quarter. For the last reported fiscal year 2024 ending Sep 30, 2024, CTXR reported annual earnings of -$40.2M, with 19.3% growth. The next CTXR earnings date is May 12, 2025.
Citius Pharmaceuticals Earnings Reports & History FAQ
What were Citius Pharmaceuticals's earnings last quarter?
On CTXR's earnings call on Invalid Date, Citius Pharmaceuticals (NASDAQ: CTXR) reported Q4 2024 earnings per share (EPS) of -$1.30, up 10.34% year over year. Total CTXR earnings for the quarter were -$9.77 million. In the same quarter last year, Citius Pharmaceuticals's earnings per share (EPS) was -$1.45.
The next CTXR earnings date is Invalid Date. Add CTXR to your watchlist to be reminded of Citius Pharmaceuticals's next earnings date.
What was CTXR's earnings growth in the past year?
As of Citius Pharmaceuticals's earnings date in Invalid Date, Citius Pharmaceuticals's earnings has grown year over year. CTXR earnings in the past year totalled -$40.72 million.
Is Citius Pharmaceuticals profitable or losing money?
As of the last Citius Pharmaceuticals earnings report, Citius Pharmaceuticals is currently losing money. Citius Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$39.68 million, a 3.92% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.